PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma.
about
PRAME expression and promoter hypomethylation in epithelial ovarian cancer.Minimal residual disease monitoring and preemptive immunotherapy in myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.PRAME as diagnostic marker and as regulator for cell fate decisions in germ cell cancers.Prominent role of RAB39A-RXRB axis in cancer development and stemness.
P2860
PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma.
@en
type
label
PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma.
@en
prefLabel
PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma.
@en
P2093
P356
P1433
P1476
PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma
@en
P2093
Basak Yavu
Berna B Duman
Cigdem U Afsar
Emine Bagir
Kahraman Tanriverdi
Melek Ergin
Meral Gunaldi
Semra Paydas
Vehbi Ercolak
P304
P356
10.1159/000381533
P577
2015-01-01T00:00:00Z